Advanced Practice Midwife in Midlothian, VA Accepting Medicare

3 Advanced Practice Midwife nurses found. Showing 1 - 3

Jean M. Curtacci, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 13700 St Francis Blvd, Suite 502, Midlothian, VA 23114 Phone: 804-423-8462    Fax: 804-423-8463

Mrs. Kimberly A Caylor, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 13700 St Francis Blvd, Suite 510, Midlothian, VA 23114 Phone: 804-423-8462    Fax: 804-423-8463

Leslie Fehan, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 13700 St Francis Blvd, Suite 606, Midlothian, VA 23114 Phone: 804-423-8462    Fax: 804-423-8463

News Archive

COBRA expansion, Medicare payments to doctors 'fix' looming over Congress

Lawmakers seek ways to expand COBRA and address the Medicare doctor payment "fix."

Alphatec Holdings prices underwritten public offering of common stock

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced that is has priced an underwritten public offering of 16,000,000 shares of common stock, consisting of 8,000,000 shares to be sold by the Company and 8,000,000 shares to be sold by a selling shareholder, HealthpointCapital Partners, L.P., at a price to the public of $5.00 per share.

Neuroscientists discover specific brain circuit that triggers cocaine relapse in mice

Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.

Romney's shifting stance on health law makes policy, political waves

The GOP presidential nominee's comments Sunday that he would keep parts of the health law triggered questions about how he would cover those with pre-existing conditions, and reinforced doubts within his own party about his commitment to repealing the overhaul. Campaign aides attempted to clarify the comments.

Santen licenses Clinical Data's ATL313 agonist compound for development of ophthalmic treatments

Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.

Read more Medical News

› Verified 4 days ago